ArticleEBioMedicine2026

Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label study.

Han Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.